Senior expertise for complex development programs.
LINQ Pharma Consulting combines regulatory insight with hands-on product development experience to help organizations make better decisions earlier—and execute them with confidence.
Dr. Onesmo Mpanju
LINQ Pharma Consulting is led by an experienced pharmaceutical and biotechnology development executive with regulatory-review and product-development experience spanning innovative medicines and biologics.
Regulatory StrategyCMCVaccinesBiologicsAdvanced TherapiesBuilt around practical, cross-functional execution.
Drug development problems rarely fit neatly within a single discipline. A manufacturing decision can change the nonclinical package; a clinical strategy can alter regulatory positioning; an agency interaction can reshape the entire program.
LINQ integrates these perspectives from the outset. We support clients from early development planning through regulatory interactions, clinical trial applications, marketing authorization and post-approval obligations.
Our working principles
- Science-led: recommendations grounded in development evidence and product risk.
- Regulatory-aware: programs designed with agency expectations and future submissions in mind.
- Execution-focused: advice translated into concrete plans, deliverables and decisions.
- Global in perspective: strategies that consider major markets and global-health pathways.